Worth Venture Partners, LLC Galera Therapeutics, Inc. Transaction History

Worth Venture Partners, LLC

  • $14.2 Million
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$1.27 - $8.28 $599,668 - $3.91 Million
-472,180 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$7.04 - $10.49 $21,162 - $31,532
3,006 Added 0.64%
472,180 $3.83 Million
Q2 2021

Aug 16, 2021
BUY
$6.08 - $10.44 $1.55 Million - $2.66 Million
254,932 Added 118.99%
469,174 $4.61 Million
Q1 2021

May 17, 2021
BUY
$8.35 - $12.39 $1.79 Million - $2.65 Million
214,242 New
214,242 $1.89 Million

Others Institutions Holding GRTX

# of Institutions
38
Shares Held
10.7M
Call Options Held
10.3K
Put Options Held
0
View Full List

About Galera Therapeutics, Inc.

GRTX Quotes by TradingView
  • Ticker GRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,821,600
  • Market Cap $3.76M
  • Description
  • Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...
More about GRTX
Track This Portfolio

Track Worth Venture Partners, LLC Portfolio

Follow Worth Venture Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Worth Venture Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Worth Venture Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email